ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$105.24

Market cap

$183.08B

P/E Ratio

32.58

Dividend/share

$2.16

EPS

$3.23

Enterprise value

$191.38B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
Abbott Laboratories's debt has decreased by 14% YoY
ABT's P/E is 9% below its 5-year quarterly average of 35.9 and 5% below its last 4 quarters average of 34.6
ABT's quick ratio is down by 11% year-on-year and by 5% since the previous quarter
The revenue has contracted by 2.8% YoY
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$183.08B
Enterprise value
$191.38B
Valuations
Price to earnings (P/E)
32.58
Price to book (P/B)
4.68
Price to sales (P/S)
4.54
EV/EBIT
26.72
EV/EBITDA
18.39
EV/Sales
4.75
Earnings
Revenue
$40.33B
EBIT
$7.16B
EBITDA
$10.41B
Free cash flow
$4.92B
Per share
EPS
$3.23
Free cash flow per share
$2.83
Book value per share
$22.5
Revenue per share
$23.17
TBVPS
$23.44
Balance sheet
Total assets
$72.47B
Total liabilities
$33.42B
Debt
$14.59B
Equity
$39.04B
Working capital
$8.36B
Liquidity
Debt to equity
0.37
Current ratio
1.6
Quick ratio
0.95
Net debt/EBITDA
0.8
Margins
EBITDA margin
25.8%
Gross margin
55.1%
Net margin
14%
Operating margin
15.8%
Efficiency
Return on assets
7.7%
Return on equity
14.7%
Return on invested capital
20.5%
Return on capital employed
12.3%
Return on sales
17.8%
Dividend
Dividend yield
2.05%
DPS
$2.16
Payout ratio
66.9%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-0.68%
1 week
3.15%
1 month
0.34%
1 year
-7.75%
YTD
-4.39%
QTD
1.28%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.33B
Gross profit
$22.22B
Operating income
$6.36B
Net income
$5.63B
Gross margin
55.1%
Net margin
14%
The operating income has contracted by 9% YoY
Abbott Laboratories's operating margin has decreased by 6% YoY and by 2.5% from the previous quarter
The revenue has contracted by 2.8% YoY
Abbott Laboratories's net income has decreased by 3% YoY

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
ABT P/E details
P/E
32.58
P/B
4.68
P/S
4.54
EV/EBIT
26.72
EV/EBITDA
18.39
EV/Sales
4.75
ABT's P/E is 9% below its 5-year quarterly average of 35.9 and 5% below its last 4 quarters average of 34.6
The EPS has contracted by 2.4% YoY
ABT's price to book (P/B) is 13% lower than its 5-year quarterly average of 5.4 and 3.9% lower than its last 4 quarters average of 4.9
ABT's equity is up by 4.9% year-on-year
ABT's P/S is 4.8% below its 5-year quarterly average of 4.8 and 2.8% below its last 4 quarters average of 4.7
The revenue has contracted by 2.8% YoY

Efficiency

How efficient is Abbott Laboratories business performance
The ROIC has contracted by 9% YoY and by 2.4% from the previous quarter
ABT's ROE is down by 7% YoY and by 2.6% from the previous quarter
Abbott Laboratories's return on assets has decreased by 2.5% YoY
The ROS has contracted by 2.2% from the previous quarter and by 2.2% YoY

Dividends

What is ABT's dividend history
Dividend details
DPS
$2.16
Dividend yield
2.05%
Payout ratio
66.9%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 117% more than the total liabilities
ABT's quick ratio is down by 11% year-on-year and by 5% since the previous quarter
Abbott Laboratories's total liabilities has decreased by 9% YoY and by 2.8% from the previous quarter
Abbott Laboratories's debt is 63% lower than its equity
Abbott Laboratories's debt to equity has decreased by 18% YoY and by 2.6% from the previous quarter
Abbott Laboratories's debt has decreased by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.